Traversa Sergio

US insider· US
Sign in for alerts
  • ACQUIREDStale

    Relmada Therapeutics Inc · NASDAQ

    +100,000 sh · $410.0K

    Filed 11 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Relmada Therapeutics Inc · NASDAQ

    +100,000 sh · $418.0K

    Filed 11 Sept 2026SEC Form 4view source